The ability of MI-319 to suppress both baseline and sunitinib-induced SDF-1 expression in our RCC xenografts is consistent with the known ability of p53 to suppress SDF-1 expression [14,15]. This evidence concerns the gene TP53 and renal cell carcinoma.